Oregon Public Employees Retirement Fund Novo Cure LTD Transaction History

Oregon Public Employees Retirement Fund

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$60.15 - $84.52 $88,661 - $124,582	-1,474 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$75.08 - $121.99 $1.04 Million - $1.7 Million	-13,900 Reduced 90.41%	1,474 $111,000
Q3 2021 Oct 19, 2021	SELL	$116.17 - $194.55 $14,637 - $24,513	-126 Reduced 0.81%	15,374 $1.79 Million
Q2 2021 Jul 23, 2021	BUY	$130.4 - $225.58 $377,508 - $653,054	2,895 Added 22.97%	15,500 $3.44 Million
Q1 2021 Apr 20, 2021	BUY	$124.11 - $190.17 $186,785 - $286,205	1,505 Added 13.56%	12,605 $1.67 Million
Q4 2020 Feb 09, 2021	BUY	$112.16 - $174.14 $1.24 Million - $1.93 Million	11,100 New	11,100 $1.92 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.03B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.